KromaTiD
Business Services · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1880 Industrial Cir Ste A, Longmont, Col...Phone Number
(720) 815-2898Website
www.kromatid.comRevenue
$8.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About KromaTiD
KROMATID specializes in genomic integrity analysis, providing high-quality single-cell data to enhance safety and efficacy in cell and gene therapy development. Their KROMASURE platform offers insights into chromosomal integrity, structural variants, and transgene mapping, catering to biotech and pharmaceutical companies, as well as regulatory professionals. The company focuses on applications such as insertional mutagenesis risk, genotoxicity profiling, and edit optimization, ensuring genomic stability from discovery to commercialization. By partnering with KROMATID, clients can make data-driven decisions to develop safer and more effective therapies for patients.Explore more
KromaTiD Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is KromaTiD your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once KromaTiD has new funding data
Earning: See what the market has to say on KromaTiD recently announced quarterly report
Click to see if KromaTiD had a recent Job posting/layoffs
KromaTiD, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if KromaTiD is spiking on competitors!
Check if KromaTiD has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at KromaTiD
Product Launch: Get notified when KromaTiD launches new products
Recommended Actions
Reach out to Masked Content who joined KromaTiD as Masked Content
Find more new buyers
Compare Similar Companies to KromaTiD
Compare insights from companies similar to KromaTiD, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
KromaTiD is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
KromaTiD is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about KromaTiD.
KromaTiD financials insights
Gather financial insights about KromaTiD, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$622K
2020
Debt
$150K
2021
Debt
$274K
2025
Multiple Rounds
$15.1M
KromaTiD Tech Stack
A closer look at the technologies used by KromaTiD
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Funding
Funding
Funding
, according to a recent Form D filing, has secured $3,547,789 in Private Equity funding.
Funding
Funding
Funding
KromaTiD News & Media
KROMATID Announces Successful Close of $8 Million Series C Funding Round, Exceeding Growth Capital Goals
Funding positions KROMATID for accelerated growth in genomic analysis and gene editing technologies BOULDER, Colo., Aug. 20, 2025 /PRNewswire/ -- KROMATID, a leader in next-generation genomic structural analysis, today announced the successful close of its Series C funding round, raising...KROMATID Works With Consortium to Empower Cancer Genomics with Industry-Leading Sequencing Standards
BOULDER, Colo., July 22, 2025 /PRNewswire/ -- KROMATID proudly announces its pivotal role within a groundbreaking public–private–academic consortium - including the prestigious National Institute of Standards and Technology (NIST) Genome in a Bottle program - that has fully sequenced a...KROMATID Launches KROMASURE(TM) PinPoint: Next Generation, High-Throughput Transgene Integration Analysis
Revolutionary Single-Cell Platform Delivers Unprecedented Resolution for Genomic Insight—Gene Edited Therapy Development BOULDER, Colo., May 27, 2025 /PRNewswire/ -- KROMATID, a leader in structural genomics innovation, is proud to announce the release of an expanded capability for its...KromaTiD Expands Their Gene Therapy Analytic Assay Suite with the Addition of GLP Genomic Integrity Karyotyping Services
LONGMONT, Colo., May 7, 2024 /PRNewswire/ -- KromaTiD, a company focused on the research, development, and commercialization of single-cell genomics tools and services for the Cell and Gene Therapy (C>) Market, is launching GLP Genomic Integrity Karyotyping services at the 2024 American...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding KromaTiD
Sign Up For FreeTo access detailed company insights
KROMATID specializes in genomic integrity analysis, providing high-quality single-cell data to enhance safety and efficacy in cell and gene therapy development. Their KROMASURE platform offers insights into chromosomal integrity, structural variants, and transgene mapping, catering to biotech and pharmaceutical companies, as well as regulatory prof... Read More
